AmnioText Wound Care – Regenative Labs

AmnioText Used With A Diabetic Foot Ulcer

AmnioText Dual-Layer Patch is a sterile, dehydrated human amniotic membrane allograft intended for homologous as a barrier or covering of a patient’s at-risk wound. The donor tissue is recovered and processed aseptically, following all industry standards. All Regenative Labs amniotic membrane allografts have been tested for potentially infectious diseases and terminally sterilized to ensure the safety of each graft.

AmnioText was used in a diabetic foot ulcer (DFU) case study and aided in the overall closure rate of the wound in just seven weeks compared to the average DFU closure time of 12 weeks.
Click here to read more about a dehydrated membrane allograft application.

More About Dehydrated Membrane Allograft Application

Closure Time is Key

With any surgical incision, ulcer, or open wound, one of the most critical goals is to close the wound quickly to mitigate risk of infection. Surgery duration and prolonged ulceration are linked to an increased risk of complications. The most common complications are infection, edema, osteomyelitis, necrosis, and gangrene. These painful side effects can lead to amputations or even death. With the help of clinicians enrolled in our study program, we gather data daily that shows accelerated closing rates using our products in various wound types.

ARTICLE – Complications in Chronic Wound Healing and Associated Interventions

CALL: 1-800-891-3452

BEFORE & AFTER AMNIOTEXT™ AMNIOTIC MEMBRANE PATCHES

AmnioText Used With A Diabetic Foot Ulcer

Let's Work Together!

Closure Time is Key

BEFORE & AFTER AMNIOTEXT™ AMNIOTIC MEMBRANE PATCHES